Evidence map›Paper›PMID 35726844›Full record

ArticleThe Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology2022

Perception of COVID-19 Pandemic Among IBD Clinicians and IBD Surgeons in Black Sea Region: A Cross-Sectional Questionnaire Study.

Haydar Celasin, Murat Törüner, Sevda Aghayeva, Nuru Bayramov, Armen Vardanyan, Bella Nanaeva, Dragomir Dardanov, Sergii Podpriatov, Andriy Dorofeyev, İbrahim Ethem Geçim

Open access · diamondAbstract read
In one paragraph

Article in The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 5 countries.

Haydar CelasinDepartment of Surgery, Lokman Hekim University Faculty of Medicine, Ankara, Turkey.
Murat TörünerDepartment of Gastroenterology, Ankara University Faculty of Medicine, Ankara, Turkey.
Sevda AghayevaDepartment of Gastroenterology, Baku Medical Plaza, Baku, Azerbaijan.
Nuru BayramovDepartment of Surgery, Medical University of Azerbaijan, Baku, Azerbaijan.
Armen VardanyanRyzhikh State Scientific Research Center of Coloproctology, Moscow, Russia.
Bella NanaevaRyzhikh State Scientific Research Center of Coloproctology, Moscow, Russia.
Dragomir DardanovDepartment of Surgery, University Hospital Alexandrovska, Sofia, Bulgaria.
Sergii PodpriatovKyiv Municipal Hospital Clinic No.1, Kyiv, Ukraine.
Andriy DorofeyevNational Medical Academy of Postgraduate Education n.a. P.L. Shupic, Ukraine.
İbrahim Ethem GeçimDepartment of Surgery, Ankara University Faculty of Medicine, Ankara, Turkey.
Ankara University · TRAzerbaijan Medical University · AZState Scientific Center of Coloproctology · RUAlexandrovska Hospital · BGKyiv City Clinical Oncology Center · UALokman Hekim Üniversitesi · TRShupyk National Healthcare University of Ukraine · UA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSince December 2019, the COVID-19 pandemic has created an increasing challenge in managing inflammatory bowel dis- ease patients both medically and surgically. Although several international and national medical/surgical associations published guide- lines in this area, there is still a huge difference between daily practices and these guidelines, especially depending on regional practices and governmental policies. Therefore, we aimed to investigate and define gastroenterologists' and surgeons' fear of COVID-19 and how they have managed inflammatory bowel disease patients during this pandemic in the Black Sea region.

methodsA 20-question survey was administered to 70 gastroenterology specialists and 80 general surgeons who are mainly focused on the management of inflammatory bowel disease in 5 countries in the Black Sea region.

resultsThe majority of respondents (81.3%) mentioned that they have concerns that their inflammatory bowel disease patients were at risk of contracting COVID-19. In addition, the majority of respondents (80.3%) believed that inflammatory bowel disease itself, inde- pendent of medications, might increase the risk of contracting COVID-19. The majority of gastroenterologists told that they did not stop inflammatory bowel disease medications due to the COVID-19 pandemic unless patients had COVID-19 disease. Surgeons overwhelm- ingly reached a consensus on how to test patients for COVID-19 perioperatively and came to a conclusion on which of the patients can- not wait to be operated. Both gastroenterologists and general surgeons, usually have similar perceptions.

conclusionDespite the increasing number of definitive studies, it seems that there are still regional differences in the perception of COVID-19 and inflammatory bowel disease patient care during the pandemic.

Indexed as

COVID-19Inflammatory Bowel DiseasesBlack SeaCross-Sectional StudiesHumansPandemicsPerception

Identifiers

PMID35726844
PMCPMC9797775
OpenAlexW4283207758

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.